Free Trial

BrightSpring Health Services (BTSG) Stock Forecast & Price Target

BrightSpring Health Services logo
$17.27 +0.23 (+1.35%)
(As of 12/20/2024 05:31 PM ET)

BrightSpring Health Services - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
14

Based on 15 Wall Street analysts who have issued ratings for BrightSpring Health Services in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a hold rating, and 14 have given a buy rating for BTSG.

Consensus Price Target

$18.65
8.01% Upside
According to the 15 analysts' twelve-month price targets for BrightSpring Health Services, the average price target is $18.65. The highest price target for BTSG is $27.00, while the lowest price target for BTSG is $11.50. The average price target represents a forecasted upside of 8.01% from the current price of $17.27.
Get the Latest News and Ratings for BTSG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BrightSpring Health Services and its competitors.

Sign Up

BTSG Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
14 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
N/A
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$18.65$16.79$15.32N/A
Forecasted Upside8.01% Upside-10.44% Downside3.99% UpsideN/A
Consensus Rating
Moderate Buy
Moderate Buy
Buy
N/A

BTSG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BTSG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BrightSpring Health Services Stock vs. The Competition

TypeBrightSpring Health ServicesMedical CompaniesS&P 500
Consensus Rating Score
2.93
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside8.01% Upside25,828.59% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent BTSG News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/17/2024Morgan Stanley
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$19.00 ➝ $20.00+6.95%
12/12/2024CJS Securities
4 of 5 stars
 Initiated CoverageOutperform$27.00+46.98%
12/11/2024Bank of America
3 of 5 stars
 Boost TargetBuy ➝ Buy$19.00 ➝ $21.00+15.32%
11/27/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$17.00 ➝ $21.00+8.02%
11/4/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$17.00 ➝ $20.00+15.27%
10/30/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$16.00 ➝ $20.00+28.45%
10/11/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Gillmor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
10/3/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$15.00 ➝ $20.00+35.04%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$15.00 ➝ $18.00+24.65%
8/9/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$21.00 ➝ $18.00+55.44%
3/6/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$13.00+41.46%
2/27/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$11.50+21.56%
2/20/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/20/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$15.00+40.06%
2/20/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$18.00+68.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:20 PM ET.


BTSG Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for BrightSpring Health Services is $18.65, with a high forecast of $27.00 and a low forecast of $11.50.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BrightSpring Health Services in the last year. There is currently 1 hold rating and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BTSG shares.

According to analysts, BrightSpring Health Services's stock has a predicted upside of 8.01% based on their 12-month stock forecasts.

BrightSpring Health Services has been rated by research analysts at Bank of America, BTIG Research, CJS Securities, Guggenheim, KeyCorp, Mizuho, Morgan Stanley, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like BrightSpring Health Services more than other "medical" companies. The consensus rating score for BrightSpring Health Services is 2.93 while the average consensus rating score for "medical" companies is 2.81. Learn more on how BTSG compares to other companies.


This page (NASDAQ:BTSG) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners